Jove
Visualize
Contact Us

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

3.7K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
3.7K
Inhaled Medications01:23

Inhaled Medications

1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

1.4K
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhalation devices and patient interface: human factors.

The AAPS journal·2015
Same author

Orally inhaled drug performance testing for product development, registration, and quality control.

Journal of aerosol medicine and pulmonary drug delivery·2014
Same author

Conference report: 1st Medicon Valley Inhalation Symposium.

Therapeutic delivery·2013
Same author

Low-voltage electrohydrodynamic (EHD) spray drying of respirable particles.

Pharmaceutical development and technology·2007
Same journal

Flavonoid nanoformulations for cutaneous administration: overcoming delivery barriers for targeted therapeutics and bioavailability enhancement.

Therapeutic delivery·2026
Same journal

Optimization of nanoemulsion formulations of <i>Piper sarmentosum</i> for topical application in skin cancer.

Therapeutic delivery·2026
Same journal

An evaluation of aripiprazole long-acting injectable monthly and bimonthly in the maintenance treatment of bipolar I disorder.

Therapeutic delivery·2026
Same journal

A decision-support workflow for the selection of mathematical models in drug dissolution and release studies.

Therapeutic delivery·2026
Same journal

Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms.

Therapeutic delivery·2026
Same journal

Damp scalp application enhances follicular delivery of dutasteride loaded in liposomes compared to dry scalp.

Therapeutic delivery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 3, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.3K

Conference report: 2nd Medicon Valley Inhalation Symposium.

Orest Lastow1

  • 1Medicon Valley Inhalation Consortium AB, Industrigatan 4, SE-212 14 Malmö, Sweden. orest.lastow@mvic.se.

Therapeutic Delivery
|February 4, 2014
PubMed
Summary
This summary is machine-generated.

The 2nd Medicon Valley Inhalation Symposium focused on inhaled drug delivery and product development, highlighting inhaled biomolecules like insulin and discussing future market opportunities for inhalation platforms.

More Related Videos

Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns
08:34

Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns

Published on: September 16, 2019

11.3K
Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents
06:57

Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents

Published on: July 9, 2020

5.7K

Related Experiment Videos

Last Updated: May 3, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.3K
Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns
08:34

Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns

Published on: September 16, 2019

11.3K
Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents
06:57

Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents

Published on: July 9, 2020

5.7K

Area of Science:

  • Pharmaceutical Sciences
  • Biotechnology
  • Medical Devices

Background:

  • The 2nd Medicon Valley Inhalation Symposium convened experts to discuss advancements in inhaled drug delivery and inhalation product development.
  • The event specifically addressed the growing area of inhaled biomolecules, including insulin delivery via inhalation.

Framework:

  • The symposium's program followed the complete value chain of inhalation product development.
  • Key topics included regulatory and intellectual property aspects, manufacturing techniques for dry powder inhalers, and the benefits of nebulization and nasal delivery.

Implementation:

  • Discussions covered current market situations and future opportunities for inhalation platforms such as capsule inhalers and metered-dose inhalers.
  • Case studies and examples illustrated the advantages of nebulization and nasal delivery methods.
  • Industrial design perspectives were presented to address challenges in patient compliance with inhalation therapies.

Implications:

  • The symposium provided insights into the future of inhaled drug delivery, emphasizing innovation in product development and delivery systems.
  • It underscored the importance of addressing regulatory, manufacturing, and compliance challenges for successful inhaled therapies.
  • The event facilitated knowledge exchange among 120 delegates, fostering collaboration in the field of inhalation technology.